Compliance to intravitreal anti-vascular endothelial growth factors for treatment of retinal diseases in Nigerians: a retrospective multicenter study

Retinal Diseases

Effectiveness and Safety of Biosimilar Anti-Vascular Endothelial Growth Factor for Retinal Diseases: A Systematic Review and Meta-Analysis

Retina

Pandya BU, Mihalache A, Huang RS, Jhaveri A, Cao X, Ballios B, Felfeli T

doi: 10.1097/IAE.0000000000004807

Cataracts

Impact of intravitreal anti-vascular endothelial growth factor injections on cataract development

Ophthalmology

Choi J, Choi E, Kang SW, Kim SJ, Hwang S, Lee H

doi: 10.1016/j.ophtha.2026.03.009

Retinal Diseases

Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis

Surv Ophthalmol

Sadek K, Yu P, Butt FR, Tao BK, Al-Ani A, Yeung S, Pereira A, Tang T, Arjmand P, Mishra A, Ing E, Yan P

doi: 10.1016/j.survophthal.2026.03.017

Retinal Diseases

Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion

Br J Ophthalmol

Hunt AR, Hashimoto Y, O'Toole L, Ponsioen TL, Jaross N, Fraser-Bell S, Kusenda P, Alforja S, Barthelmes D, Gillies MC, Fight Retinal Blindness! Investigators

doi: 10.1136/bjo-2025-328709

Macular DiseasesRetinal Diseases

Longitudinal Changes in Inner Retinal Layers in Treatment-Naïve Neovascular AMD During Intravitreal Anti-VEGF Therapy

Ophthalmol Retina

Kardo H, Garweg RA, Imbach L, Garweg JG

doi: 10.1016/j.oret.2026.08.031

Retinal DiseasesFurther Publications

Risk of Retinal Detachment After Intravitreal Injection of Anti-VEGF: A Systematic Review and Meta-Analysis

Am J Ophthalmol

Mikhail D, Tao BK, Yu P, Calicchia L, Butt FR, Dhivagaran T, Al-Qattan HM, Feo A, Quarta A, Mishra AV, Seamone ME, Navajas EV, Kertes PJ, Wong DT, Muni RH, Kaplan AJ, Yan P, Popovic MM

doi: 10.1016/j.ajo.2026.05.042

Retinal Diseases

Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study

Sci Rep

Song JR, Park UC, Lee CS, Cho JJ, Kim JY, Baek SC, Jeong A, Sharma A, Kim JH, Sagong M, Woo SJ, International Retina Biosimilar Study Group (Inter BIOS Group)

doi: 10.1038/s41598-025-34325-4

Macular Diseases

Peripapillary Retinal Nerve Fibre and Ganglion Cell Layer Changes Following Intravitreal Aflibercept 8 mg Therapy in Neovascular Age-Related Macular Degeneration: A Longitudinal OCT Study

Ophthalmol Ther

Volpe G, Bonanata M, Peyla A, Ruscitti L, Eggarter V, Pache M, Paris A, Menghini M, Grimaldi G

doi: 10.1007/s40123-026-01431-z

Retinal Diseases

Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study

Sci Rep

Song JR, Jeon J, Baek SC, Sharma A, Sagong M, Lee CS, Woo SJ, International Retina Biosimilar Study Group (Inter BIOS Group)

doi: 10.1038/s41598-026-52212-4

Related content

Effectiveness and Safety of Biosimilar Anti-Vascular Endothelial Growth Factor for Retinal Diseases: A Systematic Review and Meta-Analysis

Impact of intravitreal anti-vascular endothelial growth factor injections on cataract development

Anti-vascular endothelial growth factor and choroidal thickness in retinal vein occlusion: A systematic review and meta-analysis

Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion

Longitudinal Changes in Inner Retinal Layers in Treatment-Naïve Neovascular AMD During Intravitreal Anti-VEGF Therapy

Risk of Retinal Detachment After Intravitreal Injection of Anti-VEGF: A Systematic Review and Meta-Analysis

Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study

Peripapillary Retinal Nerve Fibre and Ganglion Cell Layer Changes Following Intravitreal Aflibercept 8 mg Therapy in Neovascular Age-Related Macular Degeneration: A Longitudinal OCT Study

Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study